Kalytera Therapeutics' Unattributed - II Round

Kalytera Therapeutics raised a round of funding on December 23, 2014.

Kalytera Therapeutics (TSX VENTURE: KALY) is a clinical stage pharmaceutical company that is developing a portfolio of non-psychoactive cannabinoid and cannabinoid-modulating medicines that address la…

Articles about Kalytera Therapeutics' Unattributed - II Round: